Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating Activities    
Net loss $ (13,698) $ (5,960)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 932 1,280
Write-down of inventory 540 2,991
Deferred income taxes 784 192
Non-cash share-based compensation expense 257 474
Loss (gain) on sales of subsidiaries 13,708 (1,614)
(Reversal of) provision for allowance for doubtful accounts, net (26) 1,104
Other, net 13 107
Changes in operating assets and liabilities:    
Accounts receivable 2,356 630
Inventories (2,791) 284
Other assets (2,376) 12,675
Accounts payable (2,363) (3,843)
Accrued income taxes (2,722) (1,359)
Accrued and other liabilities 5,346 (5,726)
Contract liabilities (950) (814)
Net cash (used in) provided by operating activities (990) 421
Investing Activities    
Purchases of property, plant and equipment (860) (552)
Net cash disposed of in sales of subsidiaries (9,940) (1,112)
Net cash used in investing activities (10,800) (1,664)
Financing Activities    
Proceeds from the exercise of stock options 799 175
Repurchase of common stock (2,000)  
Payments on long-term debt (285) (280)
Borrowings on long-term debt   9
Net cash used in financing activities (1,486) (96)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash 578 (1,450)
Net Decrease in Cash, Cash Equivalents and Restricted Cash (12,698) (2,789)
Cash, Cash Equivalents and Restricted Cash, Beginning of Period [1] 59,134 62,496
Cash, Cash Equivalents and Restricted Cash, End of Period [1] $ 46,436 $ 59,707
[1] Includes Cash, Cash Equivalents and Restricted Cash that are included in Held-For-Sale Assets on the Condensed Consolidated Balance Sheets for periods prior to January 22, 2020.